Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 14, 2010 - Issue 6
Submit an article Journal homepage
656
Views
66
CrossRef citations to date
0
Altmetric
Reviews

The cancer stem cell paradigm: a new understanding of tumor development and treatment

Johnathan D Ebben University of Wisconsin, School of Medicine and Public Health, Department of Neurological Surgery, Brain Tumor Research Laboratory, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA
,
Daniel M Treisman University of Wisconsin, School of Medicine and Public Health, Department of Neurological Surgery, Brain Tumor Research Laboratory, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA
,
Michael Zorniak University of Wisconsin, School of Medicine and Public Health, Department of Neurological Surgery, Brain Tumor Research Laboratory, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA
,
Raman G Kutty University of Wisconsin, School of Medicine and Public Health, Department of Neurological Surgery, Brain Tumor Research Laboratory, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA
,
Paul A Clark University of Wisconsin, School of Medicine and Public Health, Department of Neurological Surgery, Brain Tumor Research Laboratory, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA; University of Wisconsin, Stem Cell and Regenerative Medicine Center, School of Medicine and Public Health, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA
&
John S Kuo University of Wisconsin, School of Medicine and Public Health, Department of Neurological Surgery, Brain Tumor Research Laboratory, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA; University of Wisconsin, Stem Cell and Regenerative Medicine Center, School of Medicine and Public Health, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA; University of Wisconsin, School of Medicine and Public Health, Department of Human Oncology, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA; University of Wisconsin, Carbone Comprehensive Cancer Center, School of Medicine and Public Health, CSC K4/879, 600 Highland Avenue, Madison, WI 53792, USA; Comprehensive Brain Tumor Program, University of Wisconsin, School of Medicine and Public Health, K3/803 CSC, Mail Code 8660, 600 Highland Avenue, Madison, WI 53792-8660, USA +1 608 261 1877; +1 608 263 1728; [email protected]
Pages 621-632 | Published online: 28 Apr 2010

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sireesha V Garimella, Siri Chandana Gampa & Pankaj Chaturvedi. (2023) Mitochondria in Cancer Stem Cells: From an Innocent Bystander to a Central Player in Therapy Resistance. Stem Cells and Cloning: Advances and Applications 16, pages 19-41.
Read now
Muhammad Saif, E. I. Ager, Penelope Field & K. J. Lilischkis. (2018) The role of cancer stem cells and the therapeutic potential of TRX-E-002-1 in ovarian cancer. Expert Opinion on Orphan Drugs 6:8, pages 465-475.
Read now
Evgenia V Dolgova, Ekaterina A Alyamkina, Yaroslav R Efremov, Valeriy P Nikolin, Nelly A Popova, Tamara V Tyrinova, Artem V Kozel, Alexandra M Minkevich, Oleg M Andrushkevich, Evgeniy L Zavyalov, Alexander V Romaschenko, Sergey I Bayborodin, Oleg S Taranov, Vladimir V Omigov, Ekaterina Ya Shevela, Vyacheslav V Stupak, Sergey V Mishinov, Vladimir A Rogachev, Anastasia S Proskurina, Vladimir I Mayorov, Mikhail A Shurdov, Alexander A Ostanin, Elena R Chernykh & Sergey S Bogachev. (2014) Identification of cancer stem cells and a strategy for their elimination. Cancer Biology & Therapy 15:10, pages 1378-1394.
Read now

Articles from other publishers (63)

Deborah Quaglio, Paola Infante, Silvia Cammarone, Lara Lamelza, Marilisa Conenna, Francesca Ghirga, Gennaro Adabbo, Luca Pisano, Lucia Di Marcotullio, Bruno Botta & Mattia Mori. (2023) Exploring the Potential of Anthraquinone‐Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH‐Dependent Tumour. Chemistry – A European Journal 29:62.
Crossref
Rafael Pereira dos Santos, Rafael Roesler, Lauro Gregianin, André T. Brunetto, Mariane da Cunha Jaeger, Algemir Lunardi Brunetto & Caroline Brunetto de Farias. (2023) Cancer Stem Cells and Chemoresistance in Ewing Sarcoma. Current Stem Cell Research & Therapy 18:7, pages 926-936.
Crossref
Jie Zeng & Xiao Xue Zeng. (2023) Systems Medicine for Precise Targeting of Glioblastoma. Molecular Biotechnology 65:10, pages 1565-1584.
Crossref
Irina V. Vorobjeva & Oleg P. Zhirnov. (2022) Modern approaches to treating cancer with oncolytic viruses. Microbiology Independent Research Journal (MIR Journal) 9:1.
Crossref
David Segura-Bautista, Guadalupe Maya-Nunez, Arturo Aguilar-Rojas, Maira Huerta-Reyes & Marco Allan Pérez-Solis. (2022) Contribution of Stemness-Linked Transcription Regulators to the Progression of Breast Cancer. Current Molecular Medicine 22:9, pages 766-778.
Crossref
Fabrizio Grandi, Hélio Amante Miot, Rafael Malagoli Rocha, Cristina Massoco Salles Gomes, Nicolle Queiroz‐Hazarbassanov, Luis Mauricio Montoya‐Florez, Bruno Cogliati & Noeme Sousa Rocha. (2022) Immunophenotypic and molecular profile of cancer stem‐cell markers in ex vivo canine transmissible venereal tumour (CTVT). Veterinary Medicine and Science 8:6, pages 2297-2306.
Crossref
И. В. Воробьева & О. П. Жирнов. (2022) Современные подходы к лечению рака онколитическими вирусами. Microbiology Independent Research Journal (MIR Journal) 9:1.
Crossref
Abhishek Dutta & Swastika Paul. (2022) Exosome‐based cancer stem cell communication: Implication for detecting and eliminating cancer stem cells. MedComm – Future Medicine 1:2.
Crossref
Deeptha Ishwar, Rupa Haldavnekar, Krishnan Venkatakrishnan & Bo Tan. (2022) Minimally invasive detection of cancer using metabolic changes in tumor-associated natural killer cells with Oncoimmune probes. Nature Communications 13:1.
Crossref
Darko Castven, Carolin Czauderna, Diana Becker, Sharon Pereira, Jennifer Schmitt, Arndt Weinmann, Viral Shah, Jovana Hajduk, Friederike Keggenhoff, Harald Binder, Tobias Keck, Stefanie Heilmann‐Heimbach, Marcus A. Wörns, Snorri S. Thorgeirsson, Kai Breuhahn, Peter R. Galle & Jens U. Marquardt. (2021) Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells. Hepatology Communications 6:5, pages 1140-1156.
Crossref
Bandarigoda N. Somatilaka, Ali Sadek, Renee M. McKay & Lu Q. Le. (2022) Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene 41:17, pages 2405-2421.
Crossref
Yue Zhang, Jiaqi WangYan RuanYi YangYuda ChengFengsheng WangChen ZhangYixiao XuLianlian LiuMeng YuBangqi RenJiangjun WangBinyu ZhaoRan YangJiaxiang XiongJiali WangJunlei ZhangRui JianYong LiuYanping Tian. (2022) Genome-Wide CRISPR Screen Identifies Puf60 as a Novel Stemness Gene of Mouse Embryonic Stem Cells . Stem Cells and Development 31:5-6, pages 132-142.
Crossref
Zahra Fakhroueian, Sadegh Rajabi, Niloufar Salehi, Mostafa Rezaei Tavirani, Shokoofe Noori & Mitra Nourbakhsh. (2021) Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells. Anti-Cancer Drugs 33:1, pages e311-e326.
Crossref
Anne-Marie Cleton-Jansen. 2022. Bone Cancer. Bone Cancer 145 156 .
Levon M. Khachigian. (2021) Emerging insights on functions of the anthelmintic flubendazole as a repurposed anticancer agent. Cancer Letters 522, pages 57-62.
Crossref
Maria Carmen Leiva, Elena Garre, Anna Gustafsson, Andreas Svanström, Yalda Bogestål, Joakim Håkansson, Anders Ståhlberg & Göran Landberg. (2020) Breast cancer patient‐derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments. Journal of Cellular Physiology 236:6, pages 4709-4724.
Crossref
Carolina Simioni, Ilaria Conti, Gabriele Varano, Cinzia Brenna, Eva Costanzi & Luca M. Neri. (2021) The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies. Frontiers in Oncology 11.
Crossref
Amr A. Soliman, Alaa A. Elzarkaa & Eduard Malik. 2021. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies 21 32 .
Fiorella Rossi, Hunter Noren, Richard Jove, Vladimir Beljanski & Karl-Henrik Grinnemo. (2020) Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Research & Therapy 11:1.
Crossref
Rupa Haldavnekar, Sivaprasad Chinnakkannu Vijayakumar, Krishnan Venkatakrishnan & Bo Tan. (2020) Prediction of Cancer Stem Cell Fate by Surface-Enhanced Raman Scattering Functionalized Nanoprobes. ACS Nano 14:11, pages 15468-15491.
Crossref
Ingrid W. Caras. (2020) Two cancer stem cell-targeted therapies in clinical trials as viewed from the standpoint of the cancer stem cell model. Stem Cells Translational Medicine 9:8, pages 821-826.
Crossref
Joana Vieira de Castro, Céline S. Gonçalves, Adília Hormigo & Bruno M. Costa. (2020) Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting. International Journal of Molecular Sciences 21:15, pages 5278.
Crossref
You-Ni Zhang, Shi-Bing Wang, Shu-Shu Song, Pei-Yang Hu, Yu-Cheng Zhou, Yi-Ping Mou & Xiao-Zhou Mou. (2020) Recent advances in targeting cancer stem cells using oncolytic viruses. Biotechnology Letters 42:6, pages 865-874.
Crossref
Wanlu Cao, Meng Li, Jiaye Liu, Shaoshi Zhang, Lisanne Noordam, Monique M. A. Verstegen, Ling Wang, Buyun Ma, Shan Li, Wenshi Wang, Michiel Bolkestein, Michael Doukas, Kan Chen, Zhongren Ma, Marco Bruno, Dave Sprengers, Jaap Kwekkeboom, Luc J. W. van der Laan, Ron Smits, Maikel P. Peppelenbosch & Qiuwei Pan. (2020) LGR5 marks targetable tumor-initiating cells in mouse liver cancer. Nature Communications 11:1.
Crossref
Nastassja Terraneo, Francis Jacob, Anna Dubrovska & Jürgen Grünberg. (2020) Novel Therapeutic Strategies for Ovarian Cancer Stem Cells. Frontiers in Oncology 10.
Crossref
Lorenzo Castagnoli, Francesca De Santis, Tatiana Volpari, Claudio Vernieri, Elda Tagliabue, Massimo Di Nicola & Serenella M. Pupa. (2020) Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure. Cells 9:3, pages 555.
Crossref
Yu Zhong Peng, Li Jun Yang, Hang Hong Lo, Betty Yuen Kwan Law & Vincent Kam Wai Wong. 2020. New Nanomaterials and Techniques for Tumor-targeted Systems. New Nanomaterials and Techniques for Tumor-targeted Systems 135 229 .
Vasudeva Bhat, Alison L. Allan & Afshin Raouf. (2019) Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response. Cancers 11:9, pages 1240.
Crossref
María José Gacha-Garay, Andrés Felipe Niño-Joya, Natalia I. Bolaños, Lina Abenoza, Guillermo Quintero, Humberto Ibarra, John M. Gonzalez, Verónica Akle & Zayra V. Garavito-Aguilar. (2019) Pilot Study of an Integrative New Tool for Studying Clinical Outcome Discrimination in Acute Leukemia. Frontiers in Oncology 9.
Crossref
Anwar Fathollahi, Seyed Mahmoud Hashemi, Mostafa Haji Molla Hoseini & Farshid Yeganeh. (2019) In vitro analysis of immunomodulatory effects of mesenchymal stem cell- and tumor cell -derived exosomes on recall antigen-specific responses. International Immunopharmacology 67, pages 302-310.
Crossref
Yeela Shamai, Dalia Cohn Alperovich, Zohar Yakhini, Karl Skorecki & Maty Tzukerman. (2019) Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. Stem Cells 37:2, pages 176-189.
Crossref
H. Isaac Chen, Hongjun Song & Guo-li Ming. (2019) Applications of Human Brain Organoids to Clinical Problems. Developmental Dynamics 248:1, pages 53-64.
Crossref
Paige M. Glumac & Aaron M. LeBeau. (2018) The role of CD133 in cancer: a concise review. Clinical and Translational Medicine 7:1.
Crossref
Marion Classe, Hui Yao, Roger Mouawad, Chad J. Creighton, Alice Burgess, Frederick Allanic, Michel Wassef, Xavier Leroy, Benjamin Verillaud, Geoffrey Mortuaire, Franck Bielle, Christophe Le Tourneau, Jean-Emmanuel Kurtz, David Khayat, Xiaoping Su & Gabriel G. Malouf. (2018) Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny. Cell Reports 25:3, pages 811-821.e5.
Crossref
Agnieszka Majkowska-Pilip, Maria Rius, Frank Bruchertseifer, Christos Apostolidis, Mirjam Weis, Milton Bonelli, Marta Laurenza, Leszek Królicki & Alfred Morgenstern. (2018) In vitro evaluation of 225 Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme . Chemical Biology & Drug Design 92:1, pages 1344-1356.
Crossref
Shyambabu Chaurasiya, Nanhai Chen & Susanne Warner. (2018) Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms. Cancers 10:4, pages 124.
Crossref
Evgeniya V. Dolgova, Sergey V. Mishinov, Anastasiya S. Proskurina, Ekaterina A. Potter, Yaroslav R. Efremov, Sergey I. Bayborodin, Tamara V. Tyrinova, Vyacheslav V. Stupak, Alexandr A. Ostatin, Elena R. Chernykh & Sergey S. Bogachev. (2018) Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas. Technology in Cancer Research & Treatment 17, pages 153303461775381.
Crossref
Modjtaba Emadi-Baygi, Rina Sedighi, Nooshin Nourbakhsh & Parvaneh Nikpour. (2017) Pseudogenes in gastric cancer pathogenesis: a review article. Briefings in Functional Genomics 16:6, pages 348-360.
Crossref
Sho MIYAMOTO, Takayuki KANASEKI, Yoshihiko HIROHASHI, Tomohide TSUKAHARA, Yasuhiro KIKUCHI, Noriyuki SATO & Toshihiko TORIGOE. (2017) Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy. Japanese Journal of Clinical Immunology 40:1, pages 40-47.
Crossref
Peyman Ranji, Tayyebali Salmani Kesejini, Sara Saeedikhoo & Ali Mohammad Alizadeh. (2016) Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance. Tumor Biology 37:10, pages 13059-13075.
Crossref
Sergey Koshkin, Anna Danilova, Grigory Raskin, Nikolai Petrov, Olga Bajenova, Stephen J. O’Brien, Alexey Tomilin & Elena Tolkunova. (2016) Primary cultures of human colon cancer as a model to study cancer stem cells. Tumor Biology 37:9, pages 12833-12842.
Crossref
Rika Fujii, Eitan R. Friedman, Jacob Richards, Kwong Y. Tsang, Christopher R. Heery, Jeffrey Schlom & James W. Hodge. (2016) Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab. Oncotarget 7:23, pages 33498-33511.
Crossref
Amoura Abouelnaga, Ghada A. Mutawa, Hassan Abdelghaffar, Mohamed Sobh, Sahar Hamed & Shaker A. Mousa. (2016) Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve). Journal of Cancer Research Updates 5:2.
Crossref
Tao Wang, Sarah Shigdar, Michael P. Gantier, Yingchun Hou, Li Wang, Yong Li, Hadi Al Shamaileh, Wang Yin, Shu-Feng Zhou, Xinhan Zhao & Wei Duan. (2015) Cancer stem cell targeted therapy: progress amid controversies. Oncotarget 6:42, pages 44191-44206.
Crossref
Arafath K. Najumudeen, Itziar M. D. Posada, Benoit Lectez, Yong Zhou, Sebastian K.-J. Landor, Adyary Fallarero, Pia Vuorela, John Hancock & Daniel Abankwa. (2015) Phenotypic Screening Identifies Protein Synthesis Inhibitors as H-Ras-Nanocluster-Increasing Tumor Growth Inducers. Biochemistry 54:49, pages 7212-7221.
Crossref
Xianghui He, Baosong Li, Yang Shao, Na Zhao, Yiling Hsu, Zhixiang Zhang & Liwei Zhu. (2015) Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation. BMC Cancer 15:1.
Crossref
Natália Cristina Ciufa Kobayashi & Samuel Marcos Ribeiro de Noronha. (2015) Cancer stem cells: a new approach to tumor development. Revista da Associação Médica Brasileira 61:1, pages 86-93.
Crossref
Anne-Marie Cleton-Jansen. 2015. Bone Cancer. Bone Cancer 73 82 .
Yaki Setty. (2014) In-silico models of stem cell and developmental systems. Theoretical Biology and Medical Modelling 11:1.
Crossref
HOISEON JEONG, JINKYOUNG KIM, YOUNGSEOK LEE, JAE HONG SEO, SUNG RAN HONG & AEREE KIM. (2014) Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines. Oncology Reports 32:3, pages 1218-1224.
Crossref
Kelli B. Pointer, Paul A. Clark, Michael Zorniak, Bahauddeen M. Alrfaei & John S. Kuo. (2014) Glioblastoma cancer stem cells: Biomarker and therapeutic advances. Neurochemistry International 71, pages 1-7.
Crossref
Sarah Shigdar, Yong Li, Santanu Bhattacharya, Michael O’Connor, Chunwen Pu, Jia Lin, Tao Wang, Dongxi Xiang, Lingxue Kong, Ming Q. Wei, Yimin Zhu, Shufeng Zhou & Wei Duan. (2014) Inflammation and cancer stem cells. Cancer Letters 345:2, pages 271-278.
Crossref
Mitsutoshi Nakada, Daisuke Kita, Takuya Furuta, Takuya Watanabe, Yutaka Hayashi & Jun-Ichiro Hamada. 2014. Glioma Cell Biology. Glioma Cell Biology 47 75 .
Sagi Abelson, Yeela Shamai, Liron Berger, Karl Skorecki & Maty Tzukerman. (2013) Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations. PLoS ONE 8:12, pages e83651.
Crossref
Won Duk Joo, Irene Visintin & Gil Mor. (2013) Targeted cancer therapy – Are the days of systemic chemotherapy numbered?. Maturitas 76:4, pages 308-314.
Crossref
Peter J. Quesenberry, J. Reagan, B. Ramratnam & L. Goldberg. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 3 10 .
Jeong In Yun, Hyoung Rae Kim, Haeil Park, Sang Kyum Kim & Jongkook Lee. (2012) Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer. Archives of Pharmacal Research 35:8, pages 1317-1333.
Crossref
Parvaneh Nikpour, Modjtaba Emadi-Baygi, Faezeh Mohammad-Hashem, Mohamad Reza Maracy & Shaghayegh Haghjooy-Javanmard. (2012) Differential expression of ZFX gene in gastric cancer. Journal of Biosciences 37:1, pages 85-90.
Crossref
Sagi Abelson, Yeela Shamai, Liron Berger, Roni Shouval, Karl Skorecki & Maty Tzukerman. (2012) Intratumoral Heterogeneity in the Self‐Renewal and Tumorigenic Differentiation of Ovarian Cancer. STEM CELLS 30:3, pages 415-424.
Crossref
Sarah ShigdarJia LinYong Li, Chaoyong James Yang, Mingqian Wei, Yimin Zhu, Hui Liu & Wei Duan. (2012) Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging. Therapeutic Delivery 3:2, pages 227-244.
Crossref
Xi Zhou, Guang-Rong Huang & Pin Hu. (2011) Over-expression of Oct4 in human esophageal squamous cell carcinoma. Molecules and Cells 32:1, pages 39-45.
Crossref
Hans Clevers. (2011) The cancer stem cell: premises, promises and challenges. Nature Medicine 17:3, pages 313-319.
Crossref
Johanna M. S. Lemons, Xiao-Jiang Feng, Bryson D. Bennett, Aster Legesse-Miller, Elizabeth L. Johnson, Irene Raitman, Elizabeth A. Pollina, Herschel A. Rabitz, Joshua D. Rabinowitz & Hilary A. Coller. (2010) Quiescent Fibroblasts Exhibit High Metabolic Activity. PLoS Biology 8:10, pages e1000514.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.